RESEARCHER PROFILE

Sylvia L. Asa

← Back to Case Western Reserve University

S

Case Western Reserve University

Neuroendocrine Tumor Research AdvancesPituitary Gland Disorders and TreatmentsThyroid Cancer Diagnosis and TreatmentAdrenal and Paraganglionic TumorsThyroid and Parathyroid Surgery

Sylvia L. Asa works in Neuroendocrine Tumor Research Advances, Pituitary Gland Disorders and Treatments, Thyroid Cancer Diagnosis and Treatment, Adrenal and Paraganglionic Tumors, Thyroid and Parathyroid Surgery. Recorded institutional associations include University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center.

868Publications
100,172Citations
132H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The Immune Landscape of Cancer

    2018 · 5,739 citations
  2. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

    2018 · 3,681 citations
  3. The repertoire of mutational signatures in human cancer

    2020 · 3,468 citations
  4. Oncogenic Signaling Pathways in The Cancer Genome Atlas

    2018 · 3,175 citations
  5. Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    2014 · 3,062 citations
  6. Pan-cancer analysis of whole genomes

    2020 · 3,054 citations
  7. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

    2018 · 2,521 citations
  8. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

    2015 · 2,444 citations
  9. Comprehensive Characterization of Cancer Driver Genes and Mutations

    2018 · 2,298 citations
  10. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

    2018 · 2,172 citations
  11. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma

    2016 · 1,404 citations
  12. The prevalence of pituitary adenomas

    2004 · 1,345 citations
  13. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism

    2016 · 1,343 citations
  14. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

    2018 · 1,163 citations
  15. Overview of the 2022 WHO Classification of Thyroid Neoplasms

    2022 · 1,158 citations
  16. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

    2018 · 1,136 citations
  17. Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    2018 · 1,062 citations
  18. The evolutionary history of 2,658 cancers

    2020 · 1,046 citations
  19. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

    2022 · 1,036 citations
  20. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

    2018 · 1,022 citations
  21. American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

    2012 · 935 citations
  22. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

    2018 · 897 citations
  23. Pathogenetic mechanisms in thyroid follicular-cell neoplasia

    2006 · 893 citations
  24. Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

    1996 · 880 citations
  25. Patterns of somatic structural variation in human cancer genomes

    2020 · 866 citations

← Return to the university profile